Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506- binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population

Epigenetics

Volumn 9, Issue 2, 2014, Pages 308-317

  Brebi, Priscilla ^a,b   Maldonado, Leonel ^a   Noordhuis, Maartje G ^a,c   Ili, Carmen ^a,b   Leal, Pamela ^a,b   Garcia, Patricia ^b   Brait, Mariana ^a,d   Ribas, Judit ^e   Michailidi, Christina ^a   Perez, Jimena ^a   Soudry, Ethan ^a   Tapia, Oscar ^b   Guzman, Pablo ^b   Muñoz, Sergio ^f   Van Neste, Leander ^g   Van Criekinge, Wim ^g,h   Irizarry, Rafael ⁱ   Sidransky, David ^a   Roa, Juan C ^b,j   Guerrero Preston, Rafael ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD DE LA FRONTERA   (Chile)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^e UNIVERSITY OF LLEIDA   (Spain)

^f UNIVERSIDAD DE LA FRONTERA   (Chile)

^g MDxHealth   (Belgium)

^h GHENT UNIVERSITY   (Belgium)

ⁱ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^j PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

more..

Author keywords

Biomarkers; Cervical cancer; Companion diagnostics; MeDIP; Promoter methylation

Indexed keywords

ADULT; ARTICLE; BIOINFORMATICS; CLUSTER ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA EXTRACTION; DNA HYBRIDIZATION; DNA METHYLATION; DNA MICROARRAY; ETHNICITY; FEMALE; FK 506 BINDING PROTEIN 6 GENE; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MIDDLE AGED; PREVALENCE; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; VALIDATION PROCESS; WART VIRUS; ZINC FINGER PROTEIN 516 GENE; CHILE; COMPANION DIAGNOSTICS; ETHNOLOGY; GENETICS; HUMAN GENOME; HUMAN PAPILLOMAVIRUS TYPE 18; MEDIP; METABOLISM; PROMOTER METHYLATION; PROMOTER REGION; UTERINE CERVIX CANCER; UTERINE CERVIX TUMOR; VIROLOGY;

BIOLOGICAL MARKER; FK 506 BINDING PROTEIN; FKBP6 PROTEIN, HUMAN; TUMOR MARKER; ZINC FINGER PROTEIN;

BIOMARKERS; CERVICAL CANCER; COMPANION DIAGNOSTICS; MEDIP; PROMOTER METHYLATION;

ADULT; CHILE; DNA METHYLATION; FEMALE; GENOME, HUMAN; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; TACROLIMUS BINDING PROTEINS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; ZINC FINGERS;

EID: 84892600329     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.27120     Document Type: Article

References (48)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127:2893-917; PMID:21351269; http://dx.doi. org/10.1002/ijc.25516
2. Arbyn M, Raifu AO, Weiderpass E, Bray F, Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur J Cancer 2009; 45:2640-8; PMID:19695864; http://dx.doi. org/10.1016/j.ejca.2009.07.018
3. Lowy D. Human papillomavirus, cervical cancer prevention, and more. Vaccine 2008; 26(Suppl 10):iiiiv; PMID:18847562; http://dx.doi.org/10.1016/j. vaccine.2008.06.032
4. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007; 370:890-907; PMID:17826171; http://dx.doi.org/10.1016/S0140-6736(07)61416-0
5. Holowaty P, Miller AB, Rohan T, To T. Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst 1999; 91:252-8; PMID:10037103; http://dx.doi. org/10.1093/jnci/91.3.252
6. Arbyn M, Bergeron C, Klinkhamer P, Martin-Hirsch P, Siebers AG, Bulten J. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis. Obstet Gynecol 2008; 111:167-77; PMID:18165406; http://dx.doi.org/10.1097/01. AOG.0000296488.85807.b3
7. Boone JD, Erickson BK, Huh WK. New insights into cervical cancer screening. J Gynecol Oncol 2012; 23:282-7; PMID:23094132; http://dx.doi. org/10.3802/jgo.2012.23.4.282
8. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007; 7:11-22; PMID:17186016; http://dx.doi.org/10.1038/nrc2050
9. Dillner J, Rebolj M, Birembaut P, Petry KU, Szarewski A, Munk C, de Sanjose S, Naucler P, Lloveras B, Kjaer S, et al.; Joint European Cohort Study. Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ 2008; 337:a1754; PMID:18852164; http://dx.doi.org/10.1136/bmj. a1754
10. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, Garcia FA, Moriarty AT, Waxman AG, Wilbur DC, et al.; ACS-ASCCP-ASCP Cervical Cancer Guideline Committee. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012; 62:147-72; PMID:22422631; http://dx.doi.org/10.3322/caac.21139
11. Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risks of CIN 3+ and cervical cancer among women who test Papnegative but are HPV-positive. J Low Genit Tract Dis 2013; 17(Suppl 1):S56-63; PMID:23519306; http:// dx.doi.org/10.1097/LGT.0b013e318285437b
12. Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, Solomon D, Wentzensen N, Lawson HW; 2012 ASCCP Consensus Guidelines Conference. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. Obstet Gynecol 2013; 121:829-46; PMID:23635684; http://dx.doi. org/10.1097/AOG.0b013e3182883a34
13. Katki HA, Schiffman M, Castle PE, Fetterman B, Poitras NE, Lorey T, Cheung LC, Raine-Bennett T, Gage JC, Kinney WK. Five-year risk of recurrence after treatment of CIN 2, CIN 3, or AIS: performance of HPV and Pap cotesting in posttreatment management. J Low Genit Tract Dis 2013; 17(Suppl 1):S78-84; PMID:23519309; http://dx.doi.org/10.1097/ LGT.0b013e31828543c5
14. Schiffman M, Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol Biomarkers Prev 2013; 22:553-60; PMID:23549399; http://dx.doi. org/10.1158/1055-9965.EPI-12-1406
15. Flores YN, Bishai DM, Lorincz A, Shah KV, Lazcano-Ponce E, Hernández M, Granados-García V, Pérez R, Salmerón J. HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. Cancer Causes Control 2011; 22:261-72; PMID:21170578; http://dx.doi.org/10.1007/ s10552-010-9694-3
16. Wolffe AP, Matzke MA. Epigenetics: regulation through repression. Science 1999; 286:481-6; PMID:10521337; http://dx.doi.org/10.1126/ science.286.5439.481
17. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet 2002; 3:415-28; PMID:12042769
18. Brait M, Sidransky D. Cancer epigenetics: above and beyond. Toxicol Mech Methods 2011; 21:275-88; PMID:21495866; http://dx.doi.org/10.3109/153765 16.2011.562671
19. Maldonado L, Hoque MO. Epigenomics and ovarian carcinoma. Biomark Med 2010; 4:543-70; PMID:20701443; http://dx.doi.org/10.2217/ bmm.10.72
20. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8:286-98; PMID:17339880; http://dx.doi. org/10.1038/nrg2005
21. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003; 349:2042-54; PMID:14627790; http:// dx.doi.org/10.1056/NEJMra023075
22. Lai HC, Lin YW, Huang TH, Yan P, Huang RL, Wang HC, Liu J, Chan MW, Chu TY, Sun CA, et al. Identification of novel DNA methylation markers in cervical cancer. Int J Cancer 2008; 123:161-7; PMID:18398837; http://dx.doi.org/10.1002/ ijc.23519
23. Lendvai Á, Johannes F, Grimm C, Eijsink JJ, Wardenaar R, Volders HH, Klip HG, Hollema H, Jansen RC, Schuuring E, et al. Genome-wide methylation profiling identifies hypermethylated biomarkers in high-grade cervical intraepithelial neoplasia. Epigenetics 2012; 7:1268-78; PMID:23018867; http://dx.doi.org/10.4161/ epi.22301
24. Shivapurkar N, Sherman ME, Stastny V, Echebiri C, Rader JS, Nayar R, Bonfiglio TA, Gazdar AF, Wang SS. Evaluation of candidate methylation markers to detect cervical neoplasia. Gynecol Oncol 2007; 107:549-53; PMID:17894941; http://dx.doi. org/10.1016/j.ygyno.2007.08.057
25. Yang N, Eijsink JJ, Lendvai A, Volders HH, Klip H, Buikema HJ, van Hemel BM, Schuuring E, van der Zee AG, Wisman GB. Methylation markers for CCNA1 and C13ORF18 are strongly associated with high-grade cervical intraepithelial neoplasia and cervical cancer in cervical scrapings. Cancer Epidemiol Biomarkers Prev 2009; 18:3000-7; PMID:19843677; http://dx.doi.org/10.1158/1055-9965.EPI-09-0405
26. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646-74; PMID:21376230; http://dx.doi.org/10.1016/j. cell.2011.02.013
27. Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics 2009; 1:239-59; PMID:20495664; http://dx.doi.org/10.2217/epi.09.33
28. Feinberg AP, Ohlsson R, Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 2006; 7:21-33; PMID:16369569; http://dx.doi. org/10.1038/nrg1748
29. Walter K, Holcomb T, Januario T, Du P, Evangelista M, Kartha N, Iniguez L, Soriano R, Huw L, Stern H, et al. DNA methylation profiling defines clinically relevant biological subsets of non-small cell lung cancer. Clin Cancer Res 2012; 18:2360-73; PMID:22261801; http://dx.doi.org/10.1158/1078-0432.CCR-11-2635-T
30. Sun XW, Kuhn L, Ellerbrock TV, Chiasson MA, Bush TJ, Wright TC Jr. Human papillomavirus infection in women infected with the human immunodeficiency virus. N Engl J Med 1997; 337:1343-9; PMID:9358128; http://dx.doi.org/10.1056/ NEJM199711063371903
31. Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998; 92:727-35; PMID:9764690; http://dx.doi. org/10.1016/S0029-7844(98)00245-2
32. Trimble CL, Piantadosi S, Gravitt P, Ronnett B, Pizer E, Elko A, Wilgus B, Yutzy W, Daniel R, Shah K, et al. Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype. Clin Cancer Res 2005; 11:4717-23; PMID:16000566; http://dx.doi.org/10.1158/1078-0432.CCR-04-2599
33. Oka N, Kajita M, Nishimura R, Ohbayashi C, Sudo T. L1 gene methylation in high-risk human papillomaviruses for the prognosis of cervical intraepithelial neoplasia. Int J Gynecol Cancer 2013; 23:235-43; PMID:23314283; http://dx.doi. org/10.1097/IGC.0b013e31827da1f6
34. Wentzensen N, Sun C, Ghosh A, Kinney W, Mirabello L, Wacholder S, Shaber R, LaMere B, Clarke M, Lorincz AT, et al. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3. J Natl Cancer Inst 2012; 104:1738-49; PMID:23093560; http://dx.doi. org/10.1093/jnci/djs425
35. Vucic EA, Wilson IM, Campbell JM, Lam WL. Methylation analysis by DNA immunoprecipitation (MeDIP). Methods Mol Biol 2009; 556:141-53; PMID:19488876; http://dx.doi. org/10.1007/978-1-60327-192-9_10
36. Apostolidou S, Hadwin R, Burnell M, Jones A, Baff D, Pyndiah N, Mould T, Jacobs IJ, Beddows S, Kocjan G, et al. DNA methylation analysis in liquidbased cytology for cervical cancer screening. Int J Cancer 2009; 125:2995-3002; PMID:19609949; http://dx.doi.org/10.1002/ijc.24745
37. Huang RL, Chang CC, Su PH, Chen YC, Liao YP, Wang HC, Yo YT, Chao TK, Huang HC, Lin CY, et al. Methylomic analysis identifies frequent DNA methylation of zinc finger protein 582 (ZNF582) in cervical neoplasms. PLoS One 2012; 7:e41060; PMID:22815913; http://dx.doi.org/10.1371/journal. pone.0041060
38. Farkas SA, Milutin-Gašperov N, Grce M, Nilsson TK. Genome-wide DNA methylation assay reveals novel candidate biomarker genes in cervical cancer. Epigenetics 2013; 8:8; PMID:24030264; http:// dx.doi.org/10.4161/epi.26346
39. Meng X, Lu X, Morris CA, Keating MT. A novel human gene FKBP6 is deleted in Williams syndrome. Genomics 1998; 52:130-7; PMID:9782077; http:// dx.doi.org/10.1006/geno.1998.5412
40. Zhang W, Zhang S, Xiao C, Yang Y, Zhoucun A. Mutation screening of the FKBP6 gene and its association study with spermatogenic impairment in idiopathic infertile men. Reproduction 2007; 133:511-6; PMID:17307919; http://dx.doi.org/10.1530/ REP-06-0125
41. Burrell RA, McClelland SE, Endesfelder D, Groth P, Weller MC, Shaikh N, Domingo E, Kanu N, Dewhurst SM, Gronroos E, et al. Replication stress links structural and numerical cancer chromosomal instability. Nature 2013; 494:492-6; PMID:23446422; http://dx.doi.org/10.1038/ nature11935
42. Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri-Guerra Y, St Louis J, Villarreal-Garza C, Unger-Saldaña K, Ferreyra M, Debiasi M, et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol 2013; 14:391-436; PMID:23628188; http://dx.doi.org/10.1016/ S1470-2045(13)70048-2
43. Lie AK, Kristensen G. Human papillomavirus E6/E7 mRNA testing as a predictive marker for cervical carcinoma. Expert Rev Mol Diagn 2008; 8:405-15; PMID:18598223; http://dx.doi. org/10.1586/14737159.8.4.405
44. van den Brule AJ, Pol R, Fransen-Daalmeijer N, Schouls LM, Meijer CJ, Snijders PJ. GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes. J Clin Microbiol 2002; 40:779-87; PMID:11880393; http://dx.doi.org/10.1128/ JCM.40.3.779-787.2002
45. Scacheri PC, Crawford GE, Davis S. Statistics for ChIP-chip and DNase hypersensitivity experiments on NimbleGen arrays. Methods Enzymol 2006; 411:270-82; PMID:16939795; http://dx.doi. org/10.1016/S0076-6879(06)11014-9
46. Hoque MO, Kim MS, Ostrow KL, Liu J, Wisman GB, Park HL, Poeta ML, Jeronimo C, Henrique R, Lendvai A, et al. Genome-wide promoter analysis uncovers portions of the cancer methylome. Cancer Res 2008; 68:2661-70; PMID:18413733; http:// dx.doi.org/10.1158/0008-5472.CAN-07-5913
47. Naucler P, Ryd W, Törnberg S, Strand A, Wadell G, Elfgren K, Rådberg T, Strander B, Johansson B, Forslund O, et al. Human papillomavirus and Papanicolaou tests to screen for cervical cancer. N Engl J Med 2007; 357:1589-97; PMID:17942872; http://dx.doi.org/10.1056/NEJMoa073204
48. Astor BC, Matsushita K, Gansevoort RT, van der Velde M, Woodward M, Levey AS, Jong PE, Coresh J, Astor BC, Matsushita K, et al.; Chronic Kidney Disease Prognosis Consortium. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011; 79:1331-40; PMID:21289598; http://dx.doi.org/10.1038/ ki.2010.550